An interventional study of SIS Therapy and Conventional Physiotherapy in Chronic Nonspecific Low Back Pain, sponsored by Pamukkale University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-09-24.
Sponsored by Pamukkale University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 15 studies in Pain by Pamukkale University — 3 open to participants now, 3 under way, none of them phase 3. Pain · Pamukkale University.
Among the 15 studies in Pain by Pamukkale University, this one is the 6th largest by planned enrollment, is one of 3 that started in 2026, is one of 14 with no phase, and was the 15th registered.
10,076 studies on the registry are indexed under Pain; 1,648 are open to participants now.
Browse Pain studies →3 of the 15 studies in Pain by Pamukkale University are open now, in 1 country. Recruiting first, the newest first:
Pamukkale University · Sites in Turkey
Ages 32 wk–34 wk
Pamukkale University
Ages 18–25 · Women only
By country, each count listing its studies:
Of the 930 Pain studies recruiting now, 384 (41%) set no upper age limit and 434 (47%) stop at 75 or younger; 146 take children under 18; 220 take healthy volunteers.
This study: 18 Years to 65 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
15 studies; the count open now beside each. This study's row is marked.
First in 2006; this study’s year is marked. 3 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 60 is close to the median of 66 across 8,512 interventional studies indexed under Pain.
Median enrollment 52 across the 15 interventional studies. Of the 10 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Pamukkale University is the lead sponsor of 343 studies on the registry; 61 are open to participants now.
2 of the studies in Pain by Pamukkale University that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07839169Pamukkale UniversityEffects of SIS Therapy in Individuals With Chronic Nonspecific Low Back Pain | 2026-12-30 |
| NCT07816952Pamukkale UniversityYoung Adult Women and Wearable Posture Corrector Device | 2027-05 |
Add all 2 to your calendar (.ics) → With an account.
Among the 15 studies in Pain by Pamukkale University, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Brief Summary - buraya yapıştırın
Chronic nonspecific low back pain is a common condition that can cause pain, limitations in daily activities, and reduced quality of life. Exercise and conventional physiotherapy are commonly used to manage chronic low back pain. SIS Therapy is a physiotherapy approach intended to reduce pain and improve movement and function.
The aim of this randomized controlled trial is to investigate the effects of SIS Therapy in individuals with chronic nonspecific low back pain and to compare these effects with conventional physiotherapy.
Participants will be randomly assigned to one of two groups. The SIS Therapy group will receive SIS Therapy together with a standard exercise program consisting of lumbar stabilization and stretching exercises. The conventional physiotherapy group will receive a program consisting of heat application, transcutaneous electrical nerve stimulation (TENS), therapeutic ultrasound, and therapeutic exercise. Both groups will receive treatment twice a week for four weeks, for a total of eight sessions, and both groups will receive the same home exercise program.
Participants will be evaluated before and after the four-week treatment period. The assessments will examine changes in pain intensity, lumbar mobility, and back extensor muscle endurance.
This study is a prospective, assessor-blinded, two-arm, parallel-group randomized controlled trial designed to investigate the effects of SIS Therapy in individuals with chronic nonspecific low back pain and to compare its effects with conventional physiotherapy.
Individuals aged 18-65 years with chronic nonspecific low back pain lasting for at least three months will be screened for eligibility. Individuals with a Visual Analog Scale (VAS) pain intensity score of 4 or higher, who are able to walk independently and who voluntarily agree to participate in the study by providing written informed consent will be included.
After enrollment, participants will be randomly allocated to one of two intervention groups in a 1:1 ratio using a computer-generated randomization sequence. Allocation concealment will be achieved using sequentially numbered, opaque, sealed envelopes prepared according to the randomization sequence by a researcher independent of the study. The researcher responsible for outcome assessments will be blinded to group allocation.
Participants allocated to the SIS Therapy group will receive SIS Therapy together with a standard exercise program consisting of lumbar stabilization and stretching exercises. Participants allocated to the conventional physiotherapy group will receive a conventional physiotherapy program consisting of heat application, transcutaneous electrical nerve stimulation (TENS), therapeutic ultrasound, and therapeutic exercise. Both groups will receive treatment twice per week for four weeks, resulting in a total of eight treatment sessions. In addition, the same home exercise program will be provided to participants in both groups.
Outcome assessments will be performed at baseline before the intervention and after completion of the four-week intervention period by the same assessor under standardized conditions.
Pain intensity will be assessed using the Visual Analog Scale (VAS). Participants will indicate the intensity of their current low back pain on a 10-cm horizontal line ranging from 0, representing no pain, to 10, representing the worst or unbearable pain.
Pressure pain threshold (PPT) will also be assessed to provide a quantitative measure of mechanical pain sensitivity. A pressure algometer will be applied perpendicular to standardized measurement sites in the lumbar paraspinal region, and pressure will be gradually increased. Participants will be instructed to indicate the moment when the sensation of pressure first becomes painful. The pressure value at this point will be recorded as the pressure pain threshold. Measurements will be repeated at the predetermined sites, and the mean value will be used for analysis. Higher PPT values will indicate a higher pressure pain threshold and lower mechanical pain sensitivity.
Lumbar flexion mobility will be evaluated using the Modified Modified Schober Test (MMST). The participant will stand in an upright position, and standardized anatomical landmarks will be identified. The change in distance between the marked points during maximal forward trunk flexion will be recorded as an indicator of lumbar flexion mobility.
Static endurance of the lumbar extensor muscles will be evaluated using the Sorensen Back Extensor Endurance Test. During the test, the pelvis and lower extremities will be stabilized while the participant maintains the upper trunk in a horizontal position for as long as possible. The duration for which the position can be maintained will be recorded in seconds, with longer durations indicating greater back extensor endurance.
Functional disability related to low back pain will be evaluated using the Oswestry Disability Index (ODI). The ODI will be used to determine the degree to which low back pain affects participants' daily activities and functional status.
A total of 60 participants are planned to be enrolled in the study, with 30 participants allocated to each group. The sample size was determined based on an alpha level of 0.05, statistical power of 80%, and an anticipated effect size of Cohen's d = 0.80. The target sample size was increased to account for an anticipated dropout rate of approximately 15%.
The primary objective of the study is to determine whether SIS Therapy, when combined with an exercise program, produces changes in pain intensity compared with conventional physiotherapy in individuals with chronic nonspecific low back pain. Secondary objectives include investigating changes in pressure pain threshold, functional disability, lumbar mobility, and back extensor muscle endurance following the intervention.
Inclusion Criteria:
Aged between 18 and 65 years Having chronic nonspecific low back pain for at least 3 months Having a pain intensity of 4 or higher on the Visual Analog Scale (VAS) Being able to walk independently Volunteering to participate in the study and providing written
Exclusion Criteria:
History of lumbar spine surgery Severe neurological deficit or radiculopathy associated with disc herniation Presence of vertebral fracture, tumor, infection, or inflammatory rheumatic disease Pregnancy History of Having received physiotherapy for the lumbar region within the previous 3 months Cognitive or communication problems that may prevent compliance with the assessments
-
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Cancer (malignancy)
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants in this group will receive SIS Therapy in addition to a standard exercise program consisting of lumbar stabilization and stretching exercises. The intervention will be administered twice weekly for four weeks, for a total of eight treatment sessions. Participants will also receive a home exercise program.
Other: SIS Therapy
Participants in this group will receive conventional physiotherapy consisting of heat application, transcutaneous electrical nerve stimulation (TENS), therapeutic ultrasound, and therapeutic exercise. The intervention will be administered twice weekly for four weeks, for a total of eight treatment sessions. Participants will also receive the same home exercise program provided to the SIS Therapy group.
Other: Conventional Physiotherapy
Participants assigned to the experimental group will receive SIS Therapy in addition to a standard exercise program consisting of lumbar stabilization and stretching exercises. Treatment will be administered twice weekly for four weeks, for a total of eight treatment sessions. Participants will also receive a home exercise program.
Participants assigned to the active comparator group will receive conventional physiotherapy consisting of heat application, transcutaneous electrical nerve stimulation (TENS), therapeutic ultrasound, and therapeutic exercise. Treatment will be administered twice weekly for four weeks, for a total of eight treatment sessions. Participants will also receive the same home exercise program provided to the experimental group.
Change in Pain Intensity Assessed by the Visual Analog Scale (VAS)
Pain intensity will be assessed using the Visual Analog Scale (VAS). Participants will rate their current low back pain on a 10-cm horizontal scale ranging from 0 (no pain) to 10 (unbearable pain). Higher scores indicate greater pain intensity. Change in VAS score from baseline to the end of the 4-week intervention will be evaluated.
Time frame: Baseline and immediately after the 4-week intervention
Change in Pressure Pain Threshold Assessed by Pressure Algometry
Pressure pain threshold (PPT) will be assessed using a pressure algometer at standardized measurement sites in the lumbar paraspinal region. Pressure will be gradually increased until the participant first reports that the pressure sensation has become painful. The pressure value at this point will be recorded as the PPT. Higher PPT values indicate lower mechanical pain sensitivity.
Time frame: Pressure pain threshold (PPT) will be assessed using a pressure algometer at standardized measurement sites in the lumbar paraspinal region. Pressure will be gradually increased until the participant first reports that the pressure sensation has become p
Change in Functional Disability Assessed by the Oswestry Disability Index (ODI)
Change in Functional Disability Assessed by the Oswestry Disability Index (ODI)
Time frame: Baseline and immediately after the 4-week intervention
Change in Lumbar Flexion Mobility Assessed by the Modified Modified Schober Test (MMST)
Lumbar flexion mobility will be assessed using the Modified Modified Schober Test (MMST). The change in distance between standardized anatomical landmarks during maximal forward trunk flexion will be recorded in centimeters. A greater increase in distance indicates greater lumbar flexion mobility.
Time frame: Baseline and immediately after the 4-week intervention
Change in Back Extensor Muscle Endurance Assessed by the Sorensen Test
Back extensor muscle endurance will be assessed using the Sorensen Back Extensor Endurance Test. The duration for which the participant can maintain the standardized horizontal trunk position will be recorded in seconds. Longer durations indicate greater back extensor muscle endurance.
Time frame: Baseline and immediately after the 4-week intervention
Plan to share: No — Individual participant data (IPD) will not be shared with other researchers. Participant data will be coded and stored securely, with access restricted to the research team. The data will be used solely for the purposes of this study and the reporting of its scientific results.
Start is estimated for Oct 2026; primary completion for Dec 2026, 2 months later.
Of 3,749 non-industry interventional studies with no phase under Pain, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 23. This study's planned 2 months is below that.
Counting every sponsor, half of 3,848 studies reached it within 10 months; a quarter within 4 and three quarters within 23.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.